Oncology
BioNTech’s ASCO 2025 oncology advances: New data on bispecific antibodies, ADCs & mRNA immunotherapies
At ASCO 2025, BioNTech presented 7 abstracts on four selected …
20993 items found
News
Marvel's latest superhero aims to smash diabetes stigma
Omnya, a high school teenager who lives with type 1 diabetes, can …
News
UK follows through on doubling of statutory scheme rate
The UK pharma industry has reacted angrily to the news that the …
Spotlight on
News
BMS' radiopharma unit builds with $1.35bn Philochem deal
Bristol Myers Squibb has expanded its push into radiopharmaceuticals …
News
SpliceBio gathers $135m for eye disease gene therapies
Spanish biotech SpliceBio has raised $135 million in financing that …
News
Makary, Prasad set out their vision for the FDA
Top priorities at the FDA in the coming years will include shorter …
R&D
Transforming drug development with statistical methodologies
The product development lifecycle is long and challenging. Whether it …
News
Most pharmas not ready for AI in customer engagement
Pharma is interested in using artificial intelligence in their …
News
Beyfortus now has a direct rival after FDA OK for Enflonsia
MSD will soon enter the market for drugs used to protect infants from …
News
NewAmsterdam says lead drug may have Alzheimer's role
NewAmsterdam Pharma has said that an oral drug it is developing to …
News
MSD moves ahead in race to bring oral PCSK9 drug to market
Armed with positive results in two phase 3 trials, MSD is poised to …
Oncology
BioNTech’s ASCO 2025 oncology advances: New data on bispecif...
At ASCO 2025, BioNTech presented 7 abstracts on four selected pipeline candidates in mesothelioma, lung cancer, prostate cancer, and melanoma.
Market Access
Sponsored
Bridging research and clinical guidelines – interactive stra...
Medical affairs is evolving. Understanding how to harness real-world data and digital insights is essential.
R&D
Deep Dive: Research and Development 2025
Every breakthrough in medicine, every new treatment that changes lives, starts with research.
R&D
Life Sciences Industry Report - Biologics and Generics
The importance of biosimilars only continues to grow, driven by the potential savings they are able to deliver to healthcare systems.
Oncology
Life Sciences Industry Report - Oncology
Developments in the oncology space in 2024 brought hope to both industry and patients.
Digital
Partner Content
Axtria Ignite 2025: Leading in an Agentic Era
Axtria’s flagship event is almost here! Axtria Ignite 2025 is taking place 4th to 5th June at the Princeton Marriott at Forrestal in New Jersey. This
Patients
Partner Content
Operationalize: Expanded Access Programs comes to the West C...
Improving Global Access to Life-Changing Therapeutics...
